1. Home
  2. PAMT vs LCTX Comparison

PAMT vs LCTX Comparison

Compare PAMT & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PAMT CORP

PAMT

PAMT CORP

N/A

Current Price

$11.87

Market Cap

275.4M

Sector

Industrials

ML Signal

N/A

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

N/A

Current Price

$0.90

Market Cap

255.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PAMT
LCTX
Founded
1980
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
275.4M
255.4M
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
PAMT
LCTX
Price
$11.87
$0.90
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $5.50
AVG Volume (30 Days)
12.3K
★ 1.3M
Earning Date
10-27-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
★ $437,838,000.00
$14,556,000.00
Revenue This Year
$17.76
$4.38
Revenue Next Year
N/A
$10.80
P/E Ratio
★ N/A
N/A
Revenue Growth
1.15
★ 53.24
52 Week Low
$7.15
$0.91
52 Week High
$17.75
$2.09

Technical Indicators

Market Signals
Indicator
PAMT
LCTX
Relative Strength Index (RSI) 39.33 39.85
Support Level $10.72 $0.91
Resistance Level $13.04 $1.18
Average True Range (ATR) 0.80 0.06
MACD -0.01 -0.01
Stochastic Oscillator 15.83 21.30

Price Performance

Historical Comparison
PAMT
LCTX

About PAMT PAMT CORP

PAMT Corp is a holding company that is engaged in providing truckload dry van carrier services transporting general commodities throughout the continental United States and Mexico, as well as in certain Canadian provinces. Its freight consists of automotive parts, expedited goods, consumer goods, such as general retail store merchandise, and manufactured goods, such as heating and air conditioning units. It has one reportable segment being motor carrier.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

Share on Social Networks: